CClinicalTrials.gg
CompletedNCT03531190Updated Sep 25, 2019

Pre- and Postoperative Nutrition in Head and Neck Cancer Patients

An interventional study of Nutritional supplement (Protein + MIX) and Nutritional supplement (Protein) in Head and Neck Cancer, sponsored by University of Copenhagen. Completed at 1 site in Denmark. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2019-09-25.

Sponsored by University of Copenhagen · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
42
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The purpose of the project is to investigate the effect of wound healing of a combined pre- and postoperative oral supplement, consisting of zinc, vitamin C, arginine and multivitamin, as a supplement for adequate nutrition in patients operated for head and neck cancer.

Read the detailed description

The project will be conducted as an open, randomized intervention study, and includes patients with head and neck cancer that are planned for operation. 40 participants are allocated to the intervention or control group, respectively. For both groups, the experiment will last for five to six weeks, depending on when the trial participants are planned for surgery. The intervention group must take a dietary supplement and a protein drink for 35 days (7 days preoperatively and 28 days postoperatively), which is delivered 7 days preoperatively. The same applies to the control group that only receives protein drinks. The length of the intervention period is based on the design of previous studies. During the project, compliance will be evaluated by counting the amount of remaining dietary supplements and protein drinks that the participants return on a regular basis. The control group receives standard treatment as well as protein drinks. For all participants included in the experiment blood tests and an ultrasound scanning will be performed.

02

Conditions studied

  • Head and Neck Cancer

Keywords

  • Head and neck cancer
  • wound healing
  • pre and post-surgical nutrition
  • zinc, arginine, vitamin C, protein, oral supplements
03

In context

Head and Neck Neoplasms

2,344 studies on the registry are indexed under Head and Neck Neoplasms; 551 are open to participants now.

This study's enrollment of 42 is below the median of 47 across 1,751 interventional studies indexed under Head and Neck Neoplasms.

Browse Head and Neck Neoplasms studies →

Lead sponsor

University of Copenhagen is the lead sponsor of 450 studies on the registry; 61 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Authorized/legal age (> 18 years)
  • Patients who understand written and oral Danish, and are able to give written consent
  • Patients diagnosed with head and neck cancer, which are set for surgery
  • Patients operated on the outside of the neck

Exclusion criteria

Exclusion Criteria:

  • Patients who do not understand, speak or write Danish
  • Not Authorized/not legal age (\<18 years)
  • Pregnant and breastfeeding women
  • Patients previously employed in the field of surgery within the last 5 years (prior years)
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
42 participants (actual)

Study arms

  • Experimental
    Nutritional supplement (Protein + MIX)

    Patients are given: Nutritional Supplement of protein 2-3 times a day + MIX once daily for 35 days

    Dietary Supplement: Nutritional supplement (Protein + MIX)

  • Active comparator
    Nutritional supplement (Protein)

    Nutritional Supplement of protein as needed 2-3 times a day for 35 days

    Dietary Supplement: Nutritional supplement (Protein)

Interventions

  • Dietary supplementNutritional supplement (Protein + MIX)

    Protein supplement as needed + 750 mg vitamin C, 15 g. arginine, 35 mg. zinc and two multivitamin tablets, by mouth every day for 35 days.

  • Dietary supplementNutritional supplement (Protein)

    Protein supplement as needed

06

What researchers measure

Primary outcomes

  1. POSAS-scale (The Patient and Observer Scar Assessment Scale v2.0 / EN)

    points on POSAS-questionaire (7-70)

    Time frame: 2 months

Secondary outcomes

  1. Appearance of the scar (scale)

    blind professional rating based on rank (from photographs)(1-10)

    Time frame: 2 months

  2. Ultrasound scanning

    Number of cavities in the wound

    Time frame: 2 months

  3. Biochemical measurements (micromol/l) at start and finish

    Changes in the concentrations of micronutrients in the intervention period: p-albumin, p-C-Reactive Protein, p-cobalamin, p-folic acid, p-magnesium, p-ferritin

    Time frame: 2 months

  4. Size of the scar (cm)

    measured with ruler

    Time frame: 2 months

Other outcomes

  1. Peripheral oxygen tension (partial pressure, kPa)

    Peripheral oxygen tension measured on the finger tip

    Time frame: 2 months

  2. Difficulty in swallowing (scale)

    assessed by rank-scale (1-100)

    Time frame: 2 months

07

Study locations

1 site
  • Rigshospitalet
    Copenhagen, 2100, Denmark
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 25, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03531190
Lead sponsor
University of Copenhagen
Collaborators
Rigshospitalet, Denmark
Responsible party
Jens Rikardt Andersen (Associate Professor, University of Copenhagen) — Principal investigator
First posted
May 21, 2018
Start date
May 10, 2018
Primary completion
Nov 30, 2018
Completion
Nov 30, 2018
Last update
Sep 25, 2019

Study contacts

Jens Rikardt R Andersen, MD,MPA
principal investigator · University of Copenhagen, Department of Nutrition, Exercise and Sports

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion